Lipid News

Progress in identifying lipid domains (rafts) in living cells

Erwin London
By Erwin London
Aug. 1, 2017

Under which conditions lipid chemical heterogeneity results in the formation of coexisting lipid domains with distinct lipid compositions and properties in living cells has been a subject of intense research for decades.

In model membrane formed from lipid mixtures, spontaneous formation of tightly packed sphingolipid- and cholesterol-rich lipid domains (in the liquid-ordered state) that segregate from loosely packed domains richer in unsaturated phospholipids (in the liquid-disordered state) are detected and characterized easily.
lipidraft.png

However, analogous domains in cells are very small under most conditions — at or beyond the limit of detection for most techniques. This has led to much controversy as well as much work aiming to develop new methods to identify and characterize tiny nanodomains.

Very recent progress in living cells has been encouraging on several fronts. Studies using novel fluorescently labeled lipids with affinities for liquid-ordered domains similar to those of unlabeled lipids have revealed that specific association of raft-loving lipids with raft-localizing proteins occurs in living cells (1,2). Single-particle-tracking measurements show that these interactions are lost in living cells when even minor changes in lipid or protein structure are made if these changes abolish raft-associating physical properties.

In other studies, super-resolution microscopy in B cells has found co-localization of raft markers with, and exclusion of nonraft markers from, the vicinity of clustered B-cell receptors on a size scale similar to that of the clusters (50 nanometers to 100 nanometers). This is indicative of the formation of ordered domains around the B-cell receptors. An analogous formation of nanodomains was detected around clustered cholera toxin, a molecule long known to induce the formation of ordered domains in vitro and in cells (3).

These studies extend previous work from other labs that reported lipid-domain-based molecular interactions in these systems. This is indicative of a robust underlying phenomenon.

Advances leading to an increased ability to visualize domains and manipulate their structure promise further progress. An even higher-resolution, super-resolution microscopy approach has been developed, which may allow visualization of domains that otherwise would elude direct visualization (4).

Finally, our own lab has devised a method efficiently to replace virtually the entire complement of plasma membrane outer leaflet lipids in living cells with exogenous lipids. This may allow fine-tuned control of domain formation and properties (5).

REFERENCES

1. Komura, N. et al. Nat. Chem. Biol. 12, 402 – 410 (2016).
2. Kinoshita, M. et al. J. Cell. Biol. 216, 1183 – 1204 (2017).
3. Stone, M.B. et al. eLife 6, e19891 (2017).
4. Balzarotti, F. et al. Science 355, 606 – 612 (2017).
5. Li, G. et al. Proc. Natl. Acad. Sci. USA 113, 14025 – 14030 (2016).

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Erwin London
Erwin London

Erwin London is a distinguished professor in the department of biochemistry and cell biology and in the department of chemistry at Stony Brook University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Journal News

ApoA1 reduce atherosclerotic plaques via cell death pathway

Oct. 1, 2025

Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.